Resveratrol, Carbohydrate Restriction and Prostate Cancer Progression
白藜芦醇、碳水化合物限制与前列腺癌进展
基本信息
- 批准号:8310811
- 负责人:
- 金额:$ 30.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-09-15 至 2014-07-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAndrogensAnimalsApoptosisBody WeightCarbohydratesCaringCessation of lifeClinical ResearchClinical TrialsComplementary MedicineDataDevelopmentDietDiet ModificationDietary FatsDoseEpidemiologyFat-Restricted DietFatty acid glycerol estersFoundationsFutureGoalsGrowthHealthHumanHyperphagiaIn VitroInsulinInsulin-Like Growth Factor Binding Protein 3Insulin-Like Growth Factor IIntakeMacronutrients NutritionMalignant NeoplasmsMalignant neoplasm of prostateMorbidity - disease rateMusNecrosisPhenotypePhytochemicalProteinsPublic HealthReducing dietRelative (related person)Research DesignResveratrolRoleSignal TransductionSolidSomatomedinsTestingTransgenic MiceTransgenic OrganismsUnited StatesWeightWeight GainWorkXenograft procedureandrogen independent prostate cancerbasecancer cellcancer therapycancer typefeedingimprovedin vivomenmortalitynovelpre-clinicalpreclinical studypreventtumortumor progression
项目摘要
PUBLIC HEALTH STATEMENT
Prostate cancer is a major cause of morbidity and mortality among men in the United States. In this
proposal, we aim to develop novel non-toxic complementary treatments aimed at slowing prostate cancer
progression: dietary modification and phytopharmaceuticals. If these pre-clinical studies are successful, this
will lay a solid foundation for future clinical studies among men with prostate cancer, which eventually stand
the possibility of radically altering and improving care for men with prostate cancer.
公共卫生声明
前列腺癌是美国男性发病和死亡的主要原因。在这个
提议,我们的目标是开发旨在减缓前列腺癌的新型无毒补充疗法
进展:饮食调整和植物药物。如果这些临床前研究成功的话
将为未来男性前列腺癌临床研究奠定坚实的基础,该研究最终站得住脚
从根本上改变和改善对患有前列腺癌的男性的护理的可能性。
项目成果
期刊论文数量(16)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Racial differences in adipose tissue distribution and risk of aggressive prostate cancer among men undergoing radiotherapy.
- DOI:10.1158/1055-9965.epi-14-0236
- 发表时间:2014-11
- 期刊:
- 影响因子:0
- 作者:Allott EH;Howard LE;Song HJ;Sourbeer KN;Koontz BF;Salama JK;Freedland SJ
- 通讯作者:Freedland SJ
Postoperative statin use and risk of biochemical recurrence following radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
- DOI:10.1111/bju.12720
- 发表时间:2014-11
- 期刊:
- 影响因子:4.5
- 作者:Allott EH;Howard LE;Cooperberg MR;Kane CJ;Aronson WJ;Terris MK;Amling CL;Freedland SJ
- 通讯作者:Freedland SJ
Autoantibodies against cell surface GRP78 promote tumor growth in a murine model of melanoma.
- DOI:10.1097/cmr.0b013e3283426805
- 发表时间:2011-02
- 期刊:
- 影响因子:2.2
- 作者:de Ridder GG;Gonzalez-Gronow M;Ray R;Pizzo SV
- 通讯作者:Pizzo SV
Low-Carbohydrate Diets and Prostate Cancer: How Low Is "Low Enough"?
- DOI:10.1158/1940-6207.capr-10-0071
- 发表时间:2010-09-01
- 期刊:
- 影响因子:3.3
- 作者:Masko, Elizabeth M.;Thomas, Jean A., II;Freedland, Stephen J.
- 通讯作者:Freedland, Stephen J.
Carbohydrate restriction and lactate transporter inhibition in a mouse xenograft model of human prostate cancer.
- DOI:10.1111/j.1464-410x.2012.10971.x
- 发表时间:2012-10
- 期刊:
- 影响因子:4.5
- 作者:Kim HS;Masko EM;Poulton SL;Kennedy KM;Pizzo SV;Dewhirst MW;Freedland SJ
- 通讯作者:Freedland SJ
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stephen Jay Freedland其他文献
Stephen Jay Freedland的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stephen Jay Freedland', 18)}}的其他基金
A randomized controlled phase 2 study of the ketogenic diet for patients with newly diagnosed glioblastoma in combination with standard-of-care treatment
一项针对新诊断胶质母细胞瘤患者的生酮饮食与标准护理治疗相结合的随机对照 2 期研究
- 批准号:
10568656 - 财政年份:2023
- 资助金额:
$ 30.05万 - 项目类别:
KUH-ART: Advanced Research Training in Kidney disease, Urology and Hematology
KUH-ART:肾脏疾病、泌尿科和血液学高级研究培训
- 批准号:
10657816 - 财政年份:2021
- 资助金额:
$ 30.05万 - 项目类别:
Racial Differences in Prostate Cancer Molecular Subtyping
前列腺癌分子亚型的种族差异
- 批准号:
10381279 - 财政年份:2021
- 资助金额:
$ 30.05万 - 项目类别:
Racial Differences in Prostate Cancer Molecular Subtyping
前列腺癌分子亚型的种族差异
- 批准号:
9889065 - 财政年份:2018
- 资助金额:
$ 30.05万 - 项目类别:
Racial Differences in Prostate Cancer Molecular Subtyping
前列腺癌分子亚型的种族差异
- 批准号:
10116314 - 财政年份:2018
- 资助金额:
$ 30.05万 - 项目类别:
Racial Differences in Prostate Cancer Molecular Subtyping
前列腺癌分子亚型的种族差异
- 批准号:
10376281 - 财政年份:2018
- 资助金额:
$ 30.05万 - 项目类别:
Racial Differences in Prostate Cancer Molecular Subtyping
前列腺癌分子亚型的种族差异
- 批准号:
10524093 - 财政年份:2018
- 资助金额:
$ 30.05万 - 项目类别:
相似海外基金
Abnormalities in androgens and ovarian markers in reproductive-age racially and ethnically diverse women in a prospective longitudinal cohort
前瞻性纵向队列中不同种族和民族的育龄女性雄激素和卵巢标志物的异常
- 批准号:
10930196 - 财政年份:2023
- 资助金额:
$ 30.05万 - 项目类别:
Nonalcoholic Fatty Liver Disease (NAFLD) in Polycystic Ovary Syndrome: The Role of Androgens on Liver Injury and NAFLD Progression
多囊卵巢综合征中的非酒精性脂肪肝 (NAFLD):雄激素在肝损伤和 NAFLD 进展中的作用
- 批准号:
10735807 - 财政年份:2023
- 资助金额:
$ 30.05万 - 项目类别:
Sexual Differentiation of the Brain and Behaviour: Central and Peripheral Targets of Androgens
大脑和行为的性别分化:雄激素的中枢和外周目标
- 批准号:
RGPIN-2019-04999 - 财政年份:2022
- 资助金额:
$ 30.05万 - 项目类别:
Discovery Grants Program - Individual
Elucidation of the mechanisms by which cells recognize and respond to different levels of androgens
阐明细胞识别和响应不同水平雄激素的机制
- 批准号:
10418461 - 财政年份:2022
- 资助金额:
$ 30.05万 - 项目类别:
Influence of Androgens on Tissue-Specific Lipid Metabolites and Liver Injury in Young Women with NAFLD
雄激素对患有 NAFLD 的年轻女性组织特异性脂质代谢和肝损伤的影响
- 批准号:
10570208 - 财政年份:2022
- 资助金额:
$ 30.05万 - 项目类别:
Influence of Androgens on Tissue-Specific Lipid Metabolites and Liver Injury in Young Women with NAFLD
雄激素对患有 NAFLD 的年轻女性组织特异性脂质代谢和肝损伤的影响
- 批准号:
10355174 - 财政年份:2022
- 资助金额:
$ 30.05万 - 项目类别:
Paxillin and Androgens in the Regulation of Ovarian Follicle Development
桩蛋白和雄激素在卵巢卵泡发育调节中的作用
- 批准号:
10688086 - 财政年份:2022
- 资助金额:
$ 30.05万 - 项目类别:
Defining the impact of androgens on uterine immune cell function during endometrial tissue repair
确定子宫内膜组织修复过程中雄激素对子宫免疫细胞功能的影响
- 批准号:
2744296 - 财政年份:2022
- 资助金额:
$ 30.05万 - 项目类别:
Studentship
Use of novel 11-oxygenated androgens to improve diagnostic accuracy and therapeutics in polycystic ovary syndrome
使用新型 11-含氧雄激素提高多囊卵巢综合征的诊断准确性和治疗效果
- 批准号:
10431620 - 财政年份:2022
- 资助金额:
$ 30.05万 - 项目类别:
Paxillin and Androgens in the Regulation of Ovarian Follicle Development
桩蛋白和雄激素在卵巢卵泡发育调节中的作用
- 批准号:
10525097 - 财政年份:2022
- 资助金额:
$ 30.05万 - 项目类别: